Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population

Background To investigate oral leukoplakia (OL) and risk of upper gastrointestinal (UGI) cancer deaths in the Linxian Dysplasia Nutrition Intervention Trial (NIT) cohort. Methods A total of 3318 subjects with esophageal squamous dysplasia enrolled on 1 May 1985, and were followed up until 30 Septemb...

Full description

Bibliographic Details
Main Authors: Huan Yang, Su Zhang, Jianbing Wang, Jinhu Fan, Youlin Qiao, Philip R. Taylor
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.13595
_version_ 1818561739289001984
author Huan Yang
Su Zhang
Jianbing Wang
Jinhu Fan
Youlin Qiao
Philip R. Taylor
author_facet Huan Yang
Su Zhang
Jianbing Wang
Jinhu Fan
Youlin Qiao
Philip R. Taylor
author_sort Huan Yang
collection DOAJ
description Background To investigate oral leukoplakia (OL) and risk of upper gastrointestinal (UGI) cancer deaths in the Linxian Dysplasia Nutrition Intervention Trial (NIT) cohort. Methods A total of 3318 subjects with esophageal squamous dysplasia enrolled on 1 May 1985, and were followed up until 30 September 2015. Participants with OL at baseline were treated as an exposed group, while the remainder was selected as a control group. All subjects were followed monthly and reviewed quarterly by the Linxian Cancer Registry. Cox proportional hazard model was used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs). Results During the 30‐year follow‐up, a total of 902 UGI cancer deaths occurred, including 541 esophageal squamous cell carcinoma (ESCC) related, 284 gastric cardia carcinoma (GCC) related, and 77 gastric noncardia carcinoma (GNCC) related deaths. Relative to subjects without OL, the long‐term risk of ESCC mortality in participants with OL increased by 26.1% (HR = 1.26, 95% CI: 1.05–1.52). In the subgroup analyses, adverse effects of OL on ESCC mortality were observed especially in younger subjects (HR = 1.48, 95% CI: 1.11–1.97), females (HR = 1.44, 95% CI: 1.11–1.89), non‐smokers (HR = 1.44, 95% CI: 1.15–1.81), nondrinkers (HR = 1.28, 95% CI: 1.04–1.57), and individuals with a family history of cancer (HR = 1.37, 95% CI: 1.05–1.79). No associations were observed between OL and risk of GCC and GNCC mortality. Conclusions OL may increase the long‐term risk of ESCC mortality, especially in younger subjects, females, nondrinkers, non‐smokers, and subjects with a family cancer history. Future studies are needed to explore the potentially etiological mechanism.
first_indexed 2024-12-14T00:54:45Z
format Article
id doaj.art-5e983028c5374d629efb0efabc119d0e
institution Directory Open Access Journal
issn 1759-7706
1759-7714
language English
last_indexed 2024-12-14T00:54:45Z
publishDate 2020-10-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj.art-5e983028c5374d629efb0efabc119d0e2022-12-21T23:23:38ZengWileyThoracic Cancer1759-77061759-77142020-10-0111102804281110.1111/1759-7714.13595Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia populationHuan Yang0Su Zhang1Jianbing Wang2Jinhu Fan3Youlin Qiao4Philip R. Taylor5Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Epidemiology and Biostatistics, School of Public Health Zhejiang University School of Medicine Hangzhou ChinaDepartment of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaMetabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics National Cancer Institute, National Institutes of Health Bethesda Maryland USABackground To investigate oral leukoplakia (OL) and risk of upper gastrointestinal (UGI) cancer deaths in the Linxian Dysplasia Nutrition Intervention Trial (NIT) cohort. Methods A total of 3318 subjects with esophageal squamous dysplasia enrolled on 1 May 1985, and were followed up until 30 September 2015. Participants with OL at baseline were treated as an exposed group, while the remainder was selected as a control group. All subjects were followed monthly and reviewed quarterly by the Linxian Cancer Registry. Cox proportional hazard model was used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs). Results During the 30‐year follow‐up, a total of 902 UGI cancer deaths occurred, including 541 esophageal squamous cell carcinoma (ESCC) related, 284 gastric cardia carcinoma (GCC) related, and 77 gastric noncardia carcinoma (GNCC) related deaths. Relative to subjects without OL, the long‐term risk of ESCC mortality in participants with OL increased by 26.1% (HR = 1.26, 95% CI: 1.05–1.52). In the subgroup analyses, adverse effects of OL on ESCC mortality were observed especially in younger subjects (HR = 1.48, 95% CI: 1.11–1.97), females (HR = 1.44, 95% CI: 1.11–1.89), non‐smokers (HR = 1.44, 95% CI: 1.15–1.81), nondrinkers (HR = 1.28, 95% CI: 1.04–1.57), and individuals with a family history of cancer (HR = 1.37, 95% CI: 1.05–1.79). No associations were observed between OL and risk of GCC and GNCC mortality. Conclusions OL may increase the long‐term risk of ESCC mortality, especially in younger subjects, females, nondrinkers, non‐smokers, and subjects with a family cancer history. Future studies are needed to explore the potentially etiological mechanism.https://doi.org/10.1111/1759-7714.13595Linxian Dysplasia Nutrition Intervention Trialoral leukoplakiaupper gastrointestinal cancer
spellingShingle Huan Yang
Su Zhang
Jianbing Wang
Jinhu Fan
Youlin Qiao
Philip R. Taylor
Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
Thoracic Cancer
Linxian Dysplasia Nutrition Intervention Trial
oral leukoplakia
upper gastrointestinal cancer
title Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
title_full Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
title_fullStr Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
title_full_unstemmed Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
title_short Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
title_sort oral leukoplakia and the long term risk of upper gastrointestinal cancer deaths in the linxian dysplasia population
topic Linxian Dysplasia Nutrition Intervention Trial
oral leukoplakia
upper gastrointestinal cancer
url https://doi.org/10.1111/1759-7714.13595
work_keys_str_mv AT huanyang oralleukoplakiaandthelongtermriskofuppergastrointestinalcancerdeathsinthelinxiandysplasiapopulation
AT suzhang oralleukoplakiaandthelongtermriskofuppergastrointestinalcancerdeathsinthelinxiandysplasiapopulation
AT jianbingwang oralleukoplakiaandthelongtermriskofuppergastrointestinalcancerdeathsinthelinxiandysplasiapopulation
AT jinhufan oralleukoplakiaandthelongtermriskofuppergastrointestinalcancerdeathsinthelinxiandysplasiapopulation
AT youlinqiao oralleukoplakiaandthelongtermriskofuppergastrointestinalcancerdeathsinthelinxiandysplasiapopulation
AT philiprtaylor oralleukoplakiaandthelongtermriskofuppergastrointestinalcancerdeathsinthelinxiandysplasiapopulation